• 1
    Bregazzi VS, LaRue SM, Powers BE, Fettman MJ, Ogilvie GK and Withrow SJ. Response of feline oral squamous cell carcinoma to palliative radiation therapy. Veterinary Radiology and Ultrasound 2001; 42: 7779.
  • 2
    Brizel DM, Sibley GS, Prosnitz LR, Scher RL and Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, and Physics 1997; 38: 285289.
  • 3
    Fidel J, Lyons J, Tripp C, Houston R, Wheeler B and Ruiz A. Treatment of oral squamous cell carcinoma with accelerated radiation therapy and concomitant carboplatin in cats. Journal of Veterinary Internal Medicine 2011; 25: 504510.
  • 4
    Fidel JL, Sellon RK, Houston RK and Wheeler BA. A nine-day accelerated radiation protocol for feline squamous cell carcinoma. Veterinary Radiology and Ultrasound 2007; 48: 482485.
  • 5
    Hutson CA, Willauer CC, Walder EJ, Stone JL and Klein MK. Treatment of mandibular squamous cell carcinoma in cats by use of mandibulectomy and radiotherapy: seven cases (1987–1989). Journal of the American Veterinary Medical Association 1992; 201: 777781.
  • 6
    Jones PD, de Lorimier LP, Kitchell BE and Losonsky JM. Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma. Journal of the American Animal Hospital Association 2003; 39: 463467.
  • 7
    Martin CK, Werbeck JL, Thudi NK, Lanigan LG, Wolfe TD, Toribio RE and Rosol TJ. Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Research 2010; 70: 86078616.
  • 8
    Northrup NC, Selting KA, Rassnick KM, Kristal O, O'Brien MG, Dank G, Dhaliwal RS, Jagannatha S, Cornell KK and Gieger TL. Outcomes of cats with oral tumors treated with mandibulectomy: 42 cases. Journal of the American Animal Hospital Association 2006; 42: 350360.
  • 9
    Wypij JM, Fan TM, Fredrickson RL, Barger AM, de Lorimier LP and Charney SC. In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats. Journal of Veterinary Internal Medicine 2008; 22: 158163.
  • 10
    Anneroth G, Batsakis J and Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scandinavian Journal of Dental Research 1987; 95: 229249.
  • 11
    Nakano T and Oka K. Differential values of Ki-67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer. Cancer 1993; 72: 24012408.
  • 12
    Nakano T, Oka K, Ishikawa A and Morita S. Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer. Cancer Detection and Prevention 1998; 22: 120128.
  • 13
    Suzuki Y, Oka K, Ohno T, Kato S, Tsujii H and Nakano T. Prognostic impact of mitotic index of proliferating cell populations in cervical cancer patients treated with carbon ion beam. Cancer 2009; 115: 18751882.
  • 14
    Scholzen T and Gerdes J. The Ki-67 protein: from the known and the unknown. Journal of Cellular Physiology 2000; 182: 311322.
  • 15
    Melzer K, Guscetti F, Rohrer Bley C, Sumova A, Roos M and Kaser-Hotz B. Ki67 reactivity in nasal and periocular squamous cell carcinomas in cats treated with electron beam radiation therapy. Journal of Veterinary Internal Medicine 2006; 20: 676681.
  • 16
    Arteaga CL. Epidermal growth factor receptor dependence in human tumors: more than just expression? The Oncologist 2002; 7(Suppl. 4): 3139.
  • 17
    Herbst RS. Review of epidermal growth factor receptor biology. International Journal of Radiation Oncology, Biology, and Physics 2004; 59(Suppl. 2): 2126.
  • 18
    Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK and Milas L. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Research 2002; 62: 73507356.
  • 19
    Yoshikawa H, Ehrhart E, Charles JB, Thamm DH and Larue SM. Immunohistochemical characterization of feline oral squamous cell carcinoma. American Journal of Veterinary Research 2012; 73: 18011806.
  • 20
    Alvarez AA, Krigman HR, Whitaker RS, Dodge RK and Rodriguez GC. The prognostic significance of angiogenesis in epithelial ovarian carcinoma. Clinical Cancer Research 1999; 5: 587591.
  • 21
    Erovic BM, Neuchrist C, Berger U, El-Rabadi K and Burian M. Quantitation of microvessel density in squamous cell carcinoma of the head and neck by computer-aided image analysis. Wiener Klinische Wochenschrift 2005; 117(1–2): 5357.
  • 22
    Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. Journal of the National Cancer Institute 1992; 84: 18751887.
  • 23
    Kaanders JHAM, Wijffels KIEM, Marres HAM, Ljungkvist ASE, Pop LAM, van den Hoogen FJA, de Wilde PCM, Bussink J, Raleigh JA and van der Kogel AJ. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Research 2002; 62: 70667074.
  • 24
    Park HJ, Griffin RJ, Hui S, Levitt SH and Song CW. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiation Research 2012; 177: 311327.
  • 25
    Song CW, Park HJ, Griffin RJ and Levitt SH. Radiobiology of stereotactic radiosurgery and stereotactic body radiation therapy. In: Technical Basis of Radiation Therapy. 5 edn., SH Levitt, J Purdy, C Perez and S Vijayakumar Eds., New York, Springer-Verlag, 2012: 5161.
  • 26
    Kawaguchi K, Yamada H, Horie A and Sato K. Radiosurgical treatment of maxillary squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery 2009; 38: 12051207.
  • 27
    Kodani N, Yamazaki H, Tsubokura T, Shiomi H, Kobayashi K, Nishimura T, Aibe N, Ikeno H and Nishimura T. Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. Journal of Radiation Research 2011; 52: 2431.
  • 28
    Siddiqui F, Patel M, Khan M, McLean S, Dragovic J, Jin JY, Movsas B and Ryu S. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. International Journal of Radiation Oncology, Biology, and Physics 2009; 74: 10471053.
  • 29
    Hall E and Giaccia A. Oxygen effect and reoxygenation. In: Radiobiology for the Radiologist. 6 edn., Philadelphia, Lippincott Williams & Wilkins, 2006: 85105.
  • 30
    Weinberg R. Dialogue replaces monologue: heterotypic interactions and the biology of angiogenesis. In: The Biology of Cancer. Garland Science, New York, Taylor & Francis Group, 2007: 527586.
  • 31
    Hockel M, Schlenger K, Hockel S and Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Research 1999; 59: 45254528.
  • 32
    Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 8891.
  • 33
    Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ and Overgaard J. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiotherapy and Oncology 2005; 77: 1824.
  • 34
    Nordsmark M, Overgaard M and Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiotherapy and Oncology 1996; 41: 3139.
  • 35
    Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L and Hill RP. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. Journal of Clinical Oncology 2002; 20: 680687.
  • 36
    Knocke TH, Weitmann HD, Feldmann HJ, Selzer E and Potter R. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiotherapy and Oncology 1999; 53: 99104.
  • 37
    Milosevic M, Fyles A, Hedley D and Hill R. The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure. Seminars in Radiation Oncology 2004; 14: 249258.
  • 38
    Lyng H, Sundfor K, Trope C and Rofstad EK. Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clinical Cancer Research 2000; 6: 11041112.
  • 39
    Nordsmark M and Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiotherapy and Oncology 2000; 57: 3943.
  • 40
    Stadler P, Becker A, Feldmann HJ, Hansgen G, Dunst J, Wurschmidt F and Molls M. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. International Journal of Radiation Oncology, Biology, and Physics 1999; 44: 749754.
  • 41
    Brizel DM, Dodge RK, Clough RW and Dewhirst MW. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiotherapy and Oncology 1999; 53: 113117.
  • 42
    Dunst J, Hansgen G, Lautenschlager C, Fuchsel G and Becker A. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon. International Journal of Radiation Oncology, Biology, and Physics 1999; 43: 367373.
  • 43
    Liptak JM and Withrow SJ. Cancer of the gastrointestinal tract. In: Small Animal Clinical Oncology. SJ Withrow and DM Vail Eds., 2007: 455475.
  • 44
    Yoshikawa H, Harmon JF, Custis JT and Larue SM. Repeatability of a planning target volume expansion protocol for radiation therapy of regional lymph nodes in canine and feline patients with head tumors. Veterinary Radiology and Ultrasound 2012; 53: 667672.
  • 45
    Yoshikawa H, Randall EK, Kraft SL and Larue SM. Comparison between 2-(18)F-Fluoro-2-Deoxy- D-Glucose positron emission tomography and contrast-enhanced computed tomography for measuring gross tumor volume in cats with oral squamous cell carcinoma. Veterinary Radiology and Ultrasound 2013; 54: 307313.
  • 46
    Ladue T and Klein MK. Toxicity criteria of the veterinary radiation therapy oncology group. Veterinary Radiology and Ultrasound 2001; 42: 475476.
  • 47
    Okada Y, Mataga I, Katagiri M and Ishii K. An analysis of cervical lymph nodes metastasis in oral squamous cell carcinoma. Relationship between grade of histopathological malignancy and lymph nodes metastasis. International Journal of Oral and Maxillofacial Surgery 2003; 32: 284288.
  • 48
    Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Research and Treatment 1995; 36: 169180.
  • 49
    Thrall DE, Larue SM, Pruitt AF, Case B and Dewhirst MW. Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. International Journal of Hyperthermia 2006; 22: 365373.
  • 50
    Snyder LA, Bertone ER, Jakowski RM, Dooner MS, Jennings-Ritchie J and Moore AS. p53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma. Veterinary Pathology 2004; 41: 209214.
  • 51
    Bertone ER, Snyder LA and Moore AS. Environmental and lifestyle risk factors for oral squamous cell carcinoma in domestic cats. Journal of Veterinary Internal Medicine 2003; 17: 557562.
  • 52
    Marconato L, Buchholz J, Keller M, Bettini G, Valenti P and Kaser-Hotz B. Multimodal therapeutic approach and interdisciplinary challenge for the treatment of unresectable head and neck squamous cell carcinoma in six cats: a pilot study. Veterinary and Comparative Oncology 2012; 11: 101112.
  • 53
    Hayes A, Scase T, Miller J, Murphy S, Sparkes A and Adams V. COX-1 and COX-2 expression in feline oral squamous cell carcinoma. Journal of Comparative Pathology 2006; 135(2–3): 9399.
  • 54
    Bergkvist GT, Argyle DJ, Pang LY, Muirhead R and Yool DA. Studies on the inhibition of feline EGFR in squamous cell carcinoma: enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors. Cancer Biology and Therapy 2011; 11: 927937.
  • 55
    Looper JS, Malarkey DE, Ruslander D, Proulx D and Thrall DE. Epidermal growth factor receptor expression in feline oral squamous cell carcinomas. Veterinary and Comparative Oncology 2006; 4: 3340.
  • 56
    Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR and Brown JM. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. The Journal of Clinical Investigation 2010; 120: 694705.
  • 57
    Kerbel RS and Kamen BA. The anti-angiogenic basis of metronomic chemotherapy. Nature Reviews. Cancer 2004; 4: 423436.
  • 58
    Reddy SP, Raslan WF, Gooneratne S, Kathuria S and Marks JE. Prognostic significance of keratinization in nasopharyngeal carcinoma. American Journal of Otolaryngology 1995; 16: 103108.
  • 59
    Johansen LV, Grau C and Overgaard J. Squamous cell carcinoma of the nasopharynx–an analysis of treatment results in 149 consecutive patients. Acta Oncologica 2001; 40: 801809.
  • 60
    Taguchi T, Tsukuda M, Mikami Y, Matsuda H, Tanigaki Y, Horiuchi C, Nishimura G and Nagao J. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Auris, Nasus, Larynx 2009; 36: 199204.
  • 61
    Bergers G and Benjamin LE. Tumorigenesis and the angiogenic switch. Nature Reviews. Cancer 2003; 3: 401410.
  • 62
    Eschwege F, Bourhis J, Girinski T, Lartigau E, Guichard M, Deble D, Kepta L, Wilson GD and Luboinski B. Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience. International Journal of Radiation Oncology, Biology, and Physics 1997; 39: 849853.
  • 63
    Griffiths JR and Robinson SP. The OxyLite: a fibre-optic oxygen sensor. British Journal of Radiology 1999; 72: 627630.
  • 64
    Terris DJ and Dunphy EP. Oxygen tension measurements of head and neck cancers. Archives of Otolaryngology—Head & Neck Surgery 1994; 120: 283287.
  • 65
    Braun RD, Lanzen JL, Snyder SA and Dewhirst MW. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. American Journal of Physiology—Heart and Circulatory Physiology 2001; 280: H2533H2544.
  • 66
    Gray LH, Conger AD, Ebert M, Hornsey S and Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. British Journal of Radiology 1953; 26: 638648.
  • 67
    Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH and Broder GJ. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. International Journal of Radiation Oncology, Biology, and Physics 1988; 14: 831838.
  • 68
    Fuks Z and Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005; 8: 8991.
  • 69
    Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z and Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003; 300: 11551159.
  • 70
    Bussink J, Kaanders JH, Rijken PF, Raleigh JA and Van der Kogel AJ. Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line. Radiation Research 2000; 153: 398404.